A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

NCT00465803 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost 0.004%/timolol 0.5% ophthalmic solution
DRUG: Travoprost ophthalmic solution, 0.004%
DRUG: Timolol maleate ophthalmic solution, 0.5%

Sponsor

Alcon Research